Peter E. Boyd, SVP-Operations/Value Delivery at Aquestive Therapeutics, Inc. (AQST), bought 200 shares at $9.98 ($2K) on 2018-11-21, disclosed to the SEC on 2018-11-26.
Open-market purchase of $2k AQST by SVP-Operations/Value Delivery. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| AQST | SELL | 2025-09-29 | $63K | — | Filing → |
| AQST | SELL | 2025-09-08 | $80K | — | Filing → |
| AQST | BUY | 2022-06-15 | $4K | — | Filing → |